Kampanjeplan Azitra Inc
Avansert tidsplan
Enkel graf
Om selskapet Azitra Inc
Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. flere detaljerIPO date | 2023-06-16 |
---|---|
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://azitrainc.com |
Цена ао | 0.2002 |
Prisendring per dag: | +14.01% (0.4077) |
---|---|
Prisendring per uke: | +12% (0.415) |
Prisendring per måned: | -10.51% (0.5194) |
Prisendring over 3 måneder: | -15.49% (0.55) |
Prisendring over seks måneder: | -78.68% (2.18) |
Prisendring per år: | -49.48% (0.92) |
Prisendring over 3 år: | 0% (0.4648) |
Prisendring over 5 år: | 0% (0.4648) |
Prisendring over 10 år: | 0% (0.4648) |
Prisendring siden begynnelsen av året: | -1.53% (0.472) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Institusjoner | Volum | Dele, % |
---|---|---|
Precept Management LLC | 50000 | 0.41 |
Knollwood Investment Advisory, LLC | 41537 | 0.34 |
Warberg Asset Management LLC | 35000 | 0.29 |
Citadel Advisors Llc | 28942 | 0.24 |
Millennium Management LLC | 22427 | 0.19 |
Blackrock Inc. | 4209 | 0.03 |
UBS Group AG | 145 | 0 |
Wells Fargo & Company | 11 | 0 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Mr. Francisco D. Salva | President, CEO & Director | 427.03k | 1971 (54 år) |
Mr. Norman Staskey | CFO, Treasurer & Secretary | 314.02k | 1970 (55 år) |
Mr. Travis M. Whitfill M.P.H., Ph.D. | Co-Founder, COO & Director | 161.61k | 1990 (35 år) |
Adresse: United States, Branford. CT, 21 Business Park Drive - åpne i Google maps, åpne Yandex-kart
Nettsted: https://azitrainc.com
Nettsted: https://azitrainc.com